Sgi News 02

NewNews & BlogPress Release

SPRIM Global Investments names Susan Dallabrida as Chief Executive Officer of SPRIM Consultancy

NEW YORK – February 8, 2022 – SPRIM Global Investments announces the promotion of Susan Dallabrida, PhD, to Chief Executive Officer of SPRIM Consultancy. In her nearly 2 years with SPRIM, Susan has brought both scientific and commercial leadership to the business, boosting revenue while strengthening the company’s skill sets in clinical science and innovation. In…

News & BlogPress Release

Post Hero

BAC and Blade Announce Definitive Merger Agreement

News & BlogPress Release

AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

News & BlogPress Release

Leveraging Next Gen Tools In Rare Disease Research

Leveraging Next-Gen Tools in Rare Disease Research

News & BlogPress Release

Fibronostics Raises $8 Million in Series A Financing

News & BlogPress Release

The Critical Need For Virtual Covid 19 Clinical Trials And Patient Training

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

News & BlogPress Release

Obviohealth And Hôpital Paris Saint Joseph Announce Partnership To Track Covid 19 In Oncology Patients

ObvioHealth and Hôpital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

News & BlogPress Release

Travecta Therapeutics Announces It Has Closed Its Oversubscribed Series A Round At $27 Million

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

News & BlogPress Release

Sprim Partners With Health Catalyst To Analyze Covid 19 Impact On Nash And Nafld

SPRIM Partners with Health Catalyst to Analyze COVID-19 Impact on NASH and NAFLD

News & BlogPress Release

ObvioHealth Secures $17 Million in Latest Investment Round

News & BlogPress Release

Travecta Therapeutics Secures $15 Million in Financing